Stock Based Compensation | Note 14 – Stock Based Compensation The Company’s 2019 Incentive Plan (‘‘Plan’’), approved by the Company’s stockholders in June 2019, permits the Company to grant, among other things, stock options, restricted stock, RSUs, performance share awards and dividend equivalent rights and any one or more of the foregoing to its employees, officers, directors and consultants. A maximum of 750,000 shares of the Company’s common stock is authorized for issuance pursuant to this Plan. As of June 30, 2020, an aggregate of 224,576 shares subject to awards in the form of restricted stock (149,550 shares) and RSUs (75,026 shares) are outstanding under the Plan. Under the Company’s 2016 and 2012 equity incentive plans (collectively, the “Prior Plans”), as of June 30, 2020, (i) an aggregate of 625,875 shares in the form of restricted stock (552,125 shares) and RSUs (73,750 shares) are outstanding and have not yet vested, and (ii) with respect to 76,250 shares of common stock underlying RSUs that had been granted in 2017, 24,343 shares were deemed to have vested as of June 30, 2020, but had not been issued. In August 2020, the Compensation Committee determined that the performance metrics with respect to the 24,343 shares of common stock issuable pursuant to the restricted stock units had been satisfied – accordingly these shares were issued and RSUs with respect to the 51,907 share balance were forfeited. No additional awards may be granted under the Prior Plans. Note 14 – Stock Based Compensation (Continued) For accounting purposes, the restricted stock is not included in the shares shown as outstanding on the balance sheet until they vest; however, dividends are paid on the unvested shares. The restricted stock grants are charged to General and administrative expense over the respective vesting periods based on the market value of the common stock on the grant date. Unless earlier forfeited because the participant’s relationship with the Company terminated, unvested restricted stock awards vest on the fifth During the third quarter of each of 2020, 2019 and 2018, the Company granted RSUs exchangeable for up to 75,026, 77,776, and 76,250 shares, respectively, of common stock upon satisfaction, through June 30, 2023, June 30, 2022 and June 30, 2021, respectively, of specified conditions. Specifically, up to 50% of these RSUs vest upon achievement of metrics related to average annual total stockholder return (the “TSR Awards”), which metrics meet the definition of a market condition, and up to 50% vest upon achievement of metrics related to average annual return on capital (the “ROC Awards”), which metrics meet the definition of a performance condition. The holders of the RSUs are not entitled to dividends or to vote the underlying shares until such RSUs vest and shares are issued. Accordingly, the shares underlying these RSUs are not included in the shares shown as outstanding on the balance sheet. For the TSR Awards, a third party appraiser prepared a Monte Carlo simulation pricing model to determine the fair value, which is recognized ratably over the service period. For the ROC Awards, the fair value is based on the market value on the date of grant and the performance assumptions are re-evaluated quarterly. The Company does not recognize expense on ROC Awards which it does not expect to vest. During 2019, RSUs exchangeable in 2021 and 2022 for an aggregate of 5,250 shares were forfeited. As of June 30, 2020, based on performance and market assumptions, the fair value of the RSUs granted in 2019 and 2018 is $986,000 and $918,000, respectively. Recognition of such deferred compensation expense will be charged to General and administrative expense over the respective three-year performance cycle. None of the RSUs were forfeited or vested Note 14 – Stock Based Compensation (Continued) The following is a summary of the activity of the equity incentive plans: Three Months Ended Six Months Ended June 30, June 30, 2020 2019 2020 2019 Restricted stock grants: Number of shares — — 149,550 150,050 Average per share grant price — — $ 28.10 $ 25.70 Deferred compensation to be recognized over vesting period — — $ 4,202,000 $ 3,856,000 Number of non-vested shares: Non-vested beginning of period 701,675 689,150 674,250 651,250 Grants — — 149,550 150,050 Vested during period — — (122,125) (112,150) Forfeitures — — — — Non-vested end of period 701,675 689,150 701,675 689,150 RSU grants: Number of underlying shares — — — — Average per share grant price — — — — Deferred compensation to be recognized over vesting period — — — — Number of non-vested shares: Non-vested beginning of period 225,026 152,500 225,026 152,500 Grants — — — — Vested during period (24,343) — (24,343) — Forfeitures (51,907) — (51,907) — Non-vested end of period 148,776 152,500 148,776 152,500 Restricted stock and RSU grants: Weighted average per share value of non-vested shares (based on grant price) $ 25.65 $ 24.60 $ 25.65 $ 24.60 Value of stock vested during the period (based on grant price) $ 585,000 $ — $ 3,589,000 $ 2,304,000 Weighted average per share value of shares forfeited during the period (based on grant price) $ 24.03 $ — $ 24.03 $ — The total charge to operations: Outstanding restricted stock grants $ 884,000 $ 843,000 $ 1,759,000 $ 1,686,000 Outstanding RSUs 445,000 95,000 546,000 206,000 Total charge to operations $ 1,329,000 $ 938,000 $ 2,305,000 $ 1,892,000 As of June 30, 2020, total compensation costs of $9,583,000 and $963,000 related to non-vested restricted stock awards and RSUs, respectively, have not yet been recognized. These compensation costs will be charged to General and administrative expense over the remaining respective vesting periods. The weighted average remaining vesting period is |